Table 2.
Factors associated with aspirin prescription among HIV-infected persons and matched controls in the study cohort.
| HIV infected |
Controls |
|||
|---|---|---|---|---|
| Unadjusted OR (95% CI)a |
Adjusted OR (95% CI)a,b |
Unadjusted OR (95% CI)a |
Adjusted OR (95% CI)a,b |
|
| Age (per 10 years) |
2.31
(1.78–3.01) |
n/a |
1.95
(1.52–2.50) |
n/a |
| Male sex |
1.99
(1.11–3.58) |
n/a |
1.71
(1.12–2.62) |
n/a |
| Race | ||||
| White | 1.00 (Ref) | n/a | 1.00 (Ref) | n/a |
| Non-White |
0.57
(0.37–0.86) |
n/a | 1.28 (0.91–1.80) |
n/a |
| Insurance | ||||
| Public | 1.19 (0.79–1.80) |
1.28 (0.66–1.81) |
1.00 (0.77–1.50) |
1.19 (0.68–2.08) |
| Private | 0.81 (0.53–1.24) |
0.92 (0.46–1.81) |
1.07 (0.76–1.49) |
1.21 (0.68–2.13) |
| None | 1.05 (0.61–1.84) |
1.09 (0.59–2.02) |
0.77 (0.49–1.23) |
1.20 (0.70–1.89) |
| Tobacco use | 0.70 (0.45–1.08) |
0.80 (0.50–1.30) |
1.41 (1.01–1.96) |
1.28 (0.87–1.89) |
| Cocaine use | 0.80 (0.41–1.56) |
1.11 (0.53–2.33) |
1.27 (0.83–1.95) |
1.15 (0.68–1.93) |
| Diabetes |
2.21
(1.15–4.24) |
2.33
(1.17–4.66) |
6.82
(4.67–9.97) |
5.47
(3.62–8.27) |
| Mean SBP (per 10 mmHg) |
1.13 (0.97–1.32) |
1.16 (0.98–1.39) |
1.27
(1.14–1.43) |
1.21
(1.06–1.37) |
| Mean total cholesterol (per 10 mg/dL) |
1.03 (0.99–1.07) |
1.01 (0.94–1.08) |
0.92
(0.88–0.96) |
0.91 (0.81–1.01) |
| Mean LDL cholesterol (per 10 mg/dL) |
1.07
(1.01–1.14) |
1.06 (0.96–1.17) |
0.93
(0.88–0.98) |
1.08 (0.94–1.23) |
| Mean HDL cholesterol (per 10 mg/dL) |
0.91 (0.80–1.04) |
0.87 (0.74–1.02) |
0.89 (0.79–1.00) |
0.98 (0.85–1.13) |
Note: Bold, meets statistical significance at p-value < 0.05.
Abbreviations: CI, confidence interval; HIV, human immunodeficiency virus; n/ a, not applicable; OR, odds ratio; ref, reference.
a
Logistic regression.
b
Adjusting for all relevant clinical risk factors discussed in text.